Your browser doesn't support javascript.
loading
5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia.
McCoy, J; Cadegiani, F A; Wambier, C G; Herrera, S; Vaño-Galván, S; Mesinkovska, N A; Ramos, P M; Shapiro, J; Sinclair, R; Tosti, A; Goren, A.
Afiliação
  • McCoy J; Applied Biology, Inc., Irvine, CA, USA.
  • Cadegiani FA; Department of Clinical Endocrinology, Federal University of São Paulo Medical School, Sao Paulo, Brazil.
  • Wambier CG; Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, USA.
  • Herrera S; Infectious Diseases Unit, Ramón y Cajal Hospital, Madrid, Spain.
  • Vaño-Galván S; Dermatology Department, Ramón y Cajal Hospital, Madrid, Spain.
  • Mesinkovska NA; Department of Dermatology, University of Claifornia, Irvine, CA, USA.
  • Ramos PM; Department of Dermatology, São Paulo State University - UNESP, São Paulo, Brazil.
  • Shapiro J; Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, USA.
  • Sinclair R; Sinclair Dermatology, Melbourne, Vic., Australia.
  • Tosti A; Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.
  • Goren A; Applied Biology, Inc., Irvine, CA, USA.
J Eur Acad Dermatol Venereol ; 35(4): e243-e246, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33135263

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alopecia / Inibidores de 5-alfa Redutase / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alopecia / Inibidores de 5-alfa Redutase / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article